Stockscreener 앱 받기
11.71
0.00%
0.0012
Immunome Inc 주식(IMNM)의 최신 뉴스
Using fundamentals and technicals on Immunome Inc.July 2025 Final Week & High Yield Stock Recommendations - newser.com
Immunome Inc. stock chart pattern explained2025 Retail Activity & Community Verified Swing Trade Signals - newser.com
How institutional ownership impacts Immunome Inc. stock2025 Market Trends & Weekly Market Pulse Updates - newser.com
How Immunome Inc. stock reacts to global recession fearsCPI Data & Daily Oversold Bounce Ideas - newser.com
Does Immunome Inc. fit your quant trading model2025 Analyst Calls & Detailed Earnings Play Strategies - newser.com
Immunome, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Market reaction to Immunome Inc.’s recent newsMarket Movement Recap & Accurate Entry and Exit Point Alerts - newser.com
Key resistance and support levels for Immunome Inc.Earnings Growth Summary & Entry and Exit Point Strategies - newser.com
Can trapped investors hope for a rebound in Immunome Inc.July 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Signal strength of Immunome Inc. stock in tech scannersTrade Entry Report & Verified Swing Trading Watchlist - newser.com
Is Immunome Inc. stock attractive for income investorsQuarterly Trade Summary & Verified Entry Point Signals - newser.com
Immunome, Inc. Hits Day Low of $10.02 Amid Price Pressure - Markets Mojo
Immunome, Inc. Hits Day High with 14.13% Surge in Stock Price - Markets Mojo
Immunome, Inc. Hits Day High with Strong 8.09% Intraday Surge - Markets Mojo
How high can Immunome Inc. stock goQuarterly Trade Report & Community Consensus Trade Alerts - newser.com
Trend analysis for Immunome Inc. this weekWeekly Stock Report & AI Enhanced Trade Execution Alerts - newser.com
Goldman Sachs Sees Positive Outlook for Immunome with $26 Price Target - timothysykes.com
Will Immunome's (IMNM) Antibody Partnership Mark a Shift in Its R&D Strategy? - simplywall.st
Immunome Secures Strategic Partnerships, Boosts Market Potential - StocksToTrade
Immunome Stock On the Rise Amid Strategic Collaborations - timothysykes.com
Will Immunome's (IMNM) Antibody Collaboration Refocus Its Pipeline Expansion Strategy? - Yahoo Finance
Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts - MarketBeat
Immunome (NASDAQ:IMNM) Stock Price Down 5.9%Here's Why - MarketBeat
Immunome (IMNM) Surges 6.1%: Is This an Indication of Further Gains? - Yahoo Finance
Stocks With Rising Relative Strength: Immunome - Investor's Business Daily
Using R and stats models for Immunome Inc. forecastingForecast Cut & Long-Term Growth Plans - newser.com
Goldman Sachs Group Inc. Decreases Stake in Immunome, Inc. $IMNM - MarketBeat
Immunome (NASDAQ:IMNM) Shares Up 8%What's Next? - MarketBeat
Immunome stock a ‘buy’ on ‘rich pipeline’ of oncology therapeutics: analysts - Proactive financial news
Goldman Sachs Initiates Immunome(IMNM.US) With Buy Rating - 富途牛牛
Ranking Immunome Inc. among high performing stocks via toolsMarket Growth Review & AI Driven Price Forecasts - newser.com
The Goldman Sachs Group Initiates Coverage on Immunome (NASDAQ:IMNM) - MarketBeat
Goldman Sachs initiates coverage on Immunome stock with Buy rating - Investing.com India
1.66%
자본화:
|
볼륨(24시간):